10-K Filing

Company

PharmaCyte Biotech, Inc.

Filed

August 13, 2009

Period of Report

April 30, 2009

Accession Number

0001262463-09-000065

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →